[1]
E. A. Krum, M. Yamamoto, and M. de L. L. F. Chauffaille, “Prevalence of FMS-like tyrosine kinase 3/internal tandem duplication (FLT3/ITD+) in de novo acute myeloid leukemia patients categorized according to cytogenetic risk”, Sao Paulo Med J, vol. 127, no. 1, pp. 23–27, Jan. 2009.